| Entry |
|
| Name |
Sulfathiazole (USP/INN)
|
| Formula |
C9H9N3O2S2
|
| Exact mass |
255.0136
|
| Mol weight |
255.3167
|
| Structure |

     |
| Activity |
Antibacterial
|
| Remark |
|
| Target |
dihydropteroate synthase inhibitor [KO: K00796] |
| Pathway |
|
| Interaction |
|
| Structure map |
| Sulfonamide derivatives - sulfa drugs |
|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
D DERMATOLOGICALS
D06 ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE
D06B CHEMOTHERAPEUTICS FOR TOPICAL USE
D06BA Sulfonamides
D06BA02 Sulfathiazole
D01047 Sulfathiazole (USP/INN)
J ANTIINFECTIVES FOR SYSTEMIC USE
J01 ANTIBACTERIALS FOR SYSTEMIC USE
J01E SULFONAMIDES AND TRIMETHOPRIM
J01EB Short-acting sulfonamides
J01EB07 Sulfathiazole
D01047 Sulfathiazole (USP/INN)
Antiinfectives [BR:br08307]
Antibacterials
Folic acid biosynthesis inhibitor
dihydropteroate synthase inhibitor [KO:K00796]
Sulfonamides
Sulfathiazole [ATC:D06BA02 J01EB07]
D01047 Sulfathiazole (USP/INN)
 |
| Other DBs |
CAS: 72-14-0 PubChem: PDB-CCD: LigandBox: NIKKAJI: |
| KCF data |
 ATOM 16
1 C8y C 14.6300 -17.7800
2 S4a S 15.8200 -17.0800
3 C8x C 14.6300 -19.1800
4 C8x C 13.3700 -17.0800
5 N1b N 17.0100 -17.7800
6 O3c O 14.8400 -16.1000
7 O3c O 16.8000 -16.1000
8 C8x C 13.3700 -19.8800
9 C8x C 12.1800 -17.7800
10 C8y C 18.2700 -17.0800
11 C8y C 12.1800 -19.1800
12 N1a N 10.9200 -19.8800
13 S2x S 19.4009 -17.9053
14 C8x C 20.5352 -17.0847
15 C8x C 20.1054 -15.7523
16 N5x N 18.7054 -15.7494
BOND 17
1 1 2 1
2 1 3 1
3 1 4 2
4 2 5 1
5 2 6 2
6 2 7 2
7 3 8 2
8 4 9 1
9 5 10 1
10 8 11 1
11 11 12 1
12 9 11 2
13 10 13 1
14 13 14 1
15 14 15 2
16 15 16 1
17 10 16 2
|